Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Verified Market Research recently published a report, "Diabetic Macular Edema Market" By Product (Anti VEGF Therapies, Corticosteroid...
RETINAL DISEASE IS OUR FOCUS NASDAQ: ALIM September 2021 Forward... | September 4, 2021
Ocular Drug Delivery Technology Market to Witness Revolutionary Growth by 2026 | Alimera Sciences, EyeGate Pharma, Graybug Vision
ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Friday reported second-quarter net...
Diabetic Retinopathy Market Size is expected to reach USD 14.2 billion by 2026; Rising Incidences of Diabetes Globally to Stimulate the Market Growth iCrowd Newswire 03 Jun 2021, 02:38 GMT+10 The global Diabetic Retinopathy Market was valued at USD 10.1 billion in 2020 and is expected to reach USD 14.2 billion by 2026, exhibiting a CAGR of 5.8% during forecasted period 2020-2026. Global rise in incidences of diabetes coupled with vision concerns caused by prolonged diabetes are key factors contributing to the growth of Diabetic Retinopathy market. This comprehensive study on Diabetic Retinopa...